PlainRecalls
FDA Drug Low Class III Terminated

Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10

Reported: January 17, 2018 Initiated: December 5, 2017 #D-0153-2018

Product Description

Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10

Reason for Recall

Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL

Details

Recalling Firm
Sanofi-Aventis U.S. LLC
Units Affected
11,474 cartons of 10 syringes per carton
Distribution
Distributed nationwide.
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10. Recalled by Sanofi-Aventis U.S. LLC. Units affected: 11,474 cartons of 10 syringes per carton.
Why was this product recalled?
Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL
Which agency issued this recall?
This recall was issued by the FDA Drug on January 17, 2018. Severity: Low. Recall number: D-0153-2018.